GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Total Stockholders Equity

Mankind Pharma (BOM:543904) Total Stockholders Equity : ₹93,631 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Total Stockholders Equity?

Mankind Pharma's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹93,631 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Mankind Pharma's Book Value per Share for the quarter that ended in Mar. 2024 was ₹233.73. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Mankind Pharma's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.02.


Mankind Pharma Total Stockholders Equity Historical Data

The historical data trend for Mankind Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Total Stockholders Equity Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Total Stockholders Equity
34,853.09 47,220.02 61,552.29 - 93,630.88

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 84,284.49 - 93,630.88

Mankind Pharma  (BOM:543904) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Mankind Pharma's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Mankind Pharma's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mankind Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Mankind Pharma (BOM:543904) Business Description

Traded in Other Exchanges
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines